Literature DB >> 29623392

Clinical utility of dynamic-enhanced MRI in salivary gland tumors: retrospective study and literature review.

Takenori Ogawa1, Ikuho Kojima2, Ryo Ishii3, Maya Sakamoto2, Takaki Murata4, Takahiro Suzuki5, Kengo Kato3, Ayako Nakanome3, Akira Ohkoshi3, Eiichi Ishida3, Seiji Kakehata6, Kiyoto Shiga7, Yukio Katori3.   

Abstract

PURPOSE: To improve the diagnoses of the salivary gland tumors, a dynamic-enhanced MRI (dMRI) was investigated.
METHODS: We conducted a retrospective chart review of 93 cases of salivary gland tumors. The histological diagnoses were obtained from all patients using a surgical specimen and/or an open biopsy specimen. The dMRI as well as fine-needle aspiration cytology (FNAC) and intraoperative frozen section (IFS) were analyzed. This study focused on the time-intensity curve (TIC) after injection, peak time (Tpeak), washout ratio (WR) as well as the gradient of enhancement and washout profile.
RESULTS: The histological diagnoses included pleomorphic adenoma (PMA) in 53 cases, the Warthin tumors (WT) in 14 cases and malignant tumors (MT) in 26 cases. Incorrect diagnosis rate of FNAC and IFS were 5.2 and 8.3%, respectively. The TIC revealed differences among the three types of tumors. Tpeak as well as WR also revealed significant differences (p < 0.001). Tpeak were lower in order of WT, MT, PMA, respectively. WR of TICs at 30, 45 and 105 s after Tpeak were higher in order of WT, MT, PMA, respectively (p < 0.001). The gradient of increment and washout in the TIC curve was also an important parameter to distinguish the three types of tumors. In MT, the rapid enhancement pattern was found in high or intermediate histological grade tumors, whereas the slow enhancement pattern was exhibited in low grade tumors.
CONCLUSIONS: Our findings indicate that using Tpeak and WR, it is possible to distinguish between WT, PMA and MT. Additionally, a rapid enhancement pattern may be a potential marker for these tumors.

Entities:  

Keywords:  Diagnosis; Dynamic-enhanced MRI; Fine-needle aspiration cytology; MRI; Salivary gland tumor

Mesh:

Year:  2018        PMID: 29623392     DOI: 10.1007/s00405-018-4965-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

Review 1.  Tissue that has lost its track: Warthin's tumour.

Authors:  A Teymoortash; J A Werner
Journal:  Virchows Arch       Date:  2005-05-24       Impact factor: 4.064

2.  Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.

Authors:  Miki Hisatomi; Jun-ichi Asaumi; Yoshinobu Yanagi; Teruhisa Unetsubo; Yuu Maki; Jun Murakami; Hidenobu Matsuzaki; Yasutoshi Honda; Hironobu Konouchi
Journal:  Oral Oncol       Date:  2007-01-25       Impact factor: 5.337

3.  MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.

Authors:  A Christe; C Waldherr; R Hallett; P Zbaeren; H Thoeny
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-30       Impact factor: 3.825

4.  Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging.

Authors:  J Wang; S Takashima; F Takayama; S Kawakami; A Saito; T Matsushita; M Momose; T Ishiyama
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

5.  The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours.

Authors:  Xiaofeng Tao; Gongxin Yang; Pingzhong Wang; Yingwei Wu; Wenjing Zhu; Huimin Shi; Xin Gong; Weiqing Gao; Qiang Yu
Journal:  Dentomaxillofac Radiol       Date:  2017-04-07       Impact factor: 2.419

Review 6.  Major and minor salivary gland tumors.

Authors:  Marco Guzzo; Laura D Locati; Franz J Prott; Gemma Gatta; Mark McGurk; Lisa Licitra
Journal:  Crit Rev Oncol Hematol       Date:  2009-11-24       Impact factor: 6.312

7.  Assessment of dynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands.

Authors:  Miki Hisatomi; Jun-ichi Asaumi; Hironobu Konouchi; Yoshinobu Yanagi; Hidenobu Matsuzaki; Kanji Kishi
Journal:  Oral Oncol       Date:  2002-06       Impact factor: 5.337

8.  Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.

Authors:  Hidetake Yabuuchi; Tatsuro Fukuya; Tsuyoshi Tajima; Yoichi Hachitanda; Kichinobu Tomita; Mitsuru Koga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

9.  Parotid tumors: a 10-year experience.

Authors:  Ching-Chia Lin; Ming-Hsui Tsai; Chiu-Chen Huang; Chun-Hung Hua; Hsian-Chang Tseng; Shih-Tzu Huang
Journal:  Am J Otolaryngol       Date:  2008 Mar-Apr       Impact factor: 1.808

Review 10.  Imaging of salivary gland tumours.

Authors:  Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2007-04-30       Impact factor: 3.909

View more
  4 in total

1.  Whole exome sequencing and establishment of an organoid culture of the carcinoma showing thymus-like differentiation (CASTLE) of the parotid gland.

Authors:  Tomohiko Ishikawa; Takenori Ogawa; Ayako Nakanome; Yasunari Yamauchi; Hajime Usubuchi; Masahiro Shiihara; Takuya Yoshida; Yasunobu Okamura; Kengo Kinoshita; Yukio Katori; Toru Furukawa
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

2.  Conventional and Diffusion-Weighted MR Imaging Findings of Parotid Gland Tumors.

Authors:  Fakih Cihat Eravcı; Deniz Sözmen Cılız; Kürşat Murat Özcan; Mustafa Çolak; Mehtap Çavuşoğlu; Süleyman Emre Karakurt; Mehmet Fatih Karakuş
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-09-01

Review 3.  Advanced magnetic resonance imaging findings in salivary gland tumors.

Authors:  Erkan Gökçe; Murat Beyhan
Journal:  World J Radiol       Date:  2022-08-28

Review 4.  Cross-sectional imaging and cytologic investigations in the preoperative diagnosis of parotid gland tumors - An updated literature review.

Authors:  Sebastian Stoia; Grigore Băciuț; Manuela Lenghel; Radu Badea; Csaba Csutak; Georgeta Mihaela Rusu; Mihaela Băciuț; Tiberiu Tamaș; Emil Boțan; Gabriel Armencea; Simion Bran; Cristian Dinu
Journal:  Bosn J Basic Med Sci       Date:  2021-02-01       Impact factor: 3.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.